Views & Analysis Taking up the gauntlet A review of Cancer Research UK's Grand Challenge awards programme for the latest cancer research projects.
News Major UK market breakthrough for Keytruda in lung cancer But funding will last only two years on CDF.
Views & Analysis Digital health round-up: FDA digital unit on track Employment has begun of digital health unit engineers.
News FDA advisers back Puma breast cancer drug despite safety wor... But biotech still has several hurdles to clear - including Roche's rival.
News Keytruda wins another first with approval based on biomarker... For the first time, FDA approves drug on the basis of biomarkers, rather than location.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
